Lucence Diagnostics
In Brief This Week: Thermo Fisher Scientific, Lucence, 23andMe, Aptitude Medical Systems, More
News items for the week of Feb. 24, 2025.
Lucence LiquidHallmark Assay Gets Medicare Coverage for Advanced Solid Tumors
Data from the prospective LIQUIK-01 study supported the decision, showing noninferiority to Guardant Health's Guardant360 assay, which was already covered.
Two posters to be presented at the World Congress for Lung Cancer highlight the potential of Lucence's cell-free DNA and RNA panels for lung cancer patients.
New Products Posted to GenomeWeb: Bio-Techne, Grifols, Genome Insight, Genialis, Lucence
New products and services posted to GenomeWeb for the week of May 8, 2023.
Lucence Liquid Biopsy Test to Receive Medicare Reimbursement in Lung Cancer
Lucence's amplicon-based LiquidHallmark liquid biopsy assay will now be covered under a finalized local coverage determination from Medicare contractor Palmetto.
Sep 21, 2021
Dec 10, 2020
Lucence Obtains CLIA Certification for Palo Alto Lab
Jan 27, 2020
Nov 19, 2019